1. Home
  2. LNKS vs ALLK Comparison

LNKS vs ALLK Comparison

Compare LNKS & ALLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNKS
  • ALLK
  • Stock Information
  • Founded
  • LNKS 1995
  • ALLK 2012
  • Country
  • LNKS Malaysia
  • ALLK United States
  • Employees
  • LNKS N/A
  • ALLK N/A
  • Industry
  • LNKS
  • ALLK Biotechnology: Pharmaceutical Preparations
  • Sector
  • LNKS
  • ALLK Health Care
  • Exchange
  • LNKS NYSE
  • ALLK Nasdaq
  • Market Cap
  • LNKS 113.9M
  • ALLK 101.0M
  • IPO Year
  • LNKS 2024
  • ALLK 2018
  • Fundamental
  • Price
  • LNKS $8.59
  • ALLK $1.20
  • Analyst Decision
  • LNKS
  • ALLK Hold
  • Analyst Count
  • LNKS 0
  • ALLK 5
  • Target Price
  • LNKS N/A
  • ALLK $1.67
  • AVG Volume (30 Days)
  • LNKS 507.4K
  • ALLK 334.5K
  • Earning Date
  • LNKS 01-01-0001
  • ALLK 11-06-2024
  • Dividend Yield
  • LNKS N/A
  • ALLK N/A
  • EPS Growth
  • LNKS N/A
  • ALLK N/A
  • EPS
  • LNKS N/A
  • ALLK N/A
  • Revenue
  • LNKS $4,754,489.00
  • ALLK N/A
  • Revenue This Year
  • LNKS N/A
  • ALLK N/A
  • Revenue Next Year
  • LNKS N/A
  • ALLK N/A
  • P/E Ratio
  • LNKS N/A
  • ALLK N/A
  • Revenue Growth
  • LNKS N/A
  • ALLK N/A
  • 52 Week Low
  • LNKS N/A
  • ALLK $0.54
  • 52 Week High
  • LNKS N/A
  • ALLK $3.36
  • Technical
  • Relative Strength Index (RSI)
  • LNKS N/A
  • ALLK 57.22
  • Support Level
  • LNKS N/A
  • ALLK $1.00
  • Resistance Level
  • LNKS N/A
  • ALLK $1.10
  • Average True Range (ATR)
  • LNKS 0.00
  • ALLK 0.10
  • MACD
  • LNKS 0.00
  • ALLK 0.02
  • Stochastic Oscillator
  • LNKS 0.00
  • ALLK 52.63

About LNKS LINKERS INDUSTRIES LIMITED

Linkers Industries Ltd is a company which acts as a manufacturer and a supplier of wire, cable harnesses with their manufacturing operations in Malaysia. Wire/cable harness refers to an assembly of wires/cables bound together with straps, cable ties and electrical tapes to transmit signals or electrical power. Company works closely with customers in each stage of a product's life cycle, including design, prototyping and production. Geographically company provides services in Thailand, Malaysia, Switzerland, United States of America, and many others, maximum revenue gained from Thailand.

About ALLK Allakos Inc.

Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK006 targets Siglec-6, an inhibitory receptor expressed selectively on mast cells. Binding of AK006 to Siglec-6 is designed to activate the native inhibitory function of the receptor which in turn reduces mast cell activation.

Share on Social Networks: